IDOX (IDOX) Trading Update summary
Event summary combining transcript, slides, and related documents.
Trading Update summary
6 Jun, 2025Group trading performance
Revenue grew to approximately £45.0m for HY25, up from £43.1m in HY24, reflecting continued positive momentum.
Recurring revenue increased by about 9%, partially offset by lower non-recurring revenue as anticipated.
Adjusted EBITDA rose over 6% to around £13.9m, aligning with Board expectations.
Order intake climbed by roughly 9% to £59.0m, with notable wins in the Assets division and geospatial data solutions.
Net cash position improved to £0.2m at period end, a significant shift from £9.9m net debt at October 2024.
Strategic and operational highlights
Completed the acquisition of Plianz post-period, enhancing the Social Care offering and public sector software capabilities.
M&A pipeline remains active, supporting plans to expand the specialist software and geospatial data portfolio.
Management expresses confidence in continued profitable growth and strong positioning for the remainder of 2025.
Outlook and upcoming events
Positive momentum and strong cash performance underpin confidence for growth in the rest of 2025.
FY25 H1 results will be reported on 12 June 2025, with a management webinar scheduled for the same day.
Latest events from IDOX
- Revenue and Adjusted EBITDA rose, with a recommended takeover offer in progress.IDOX
H2 202517 Feb 2026 - Revenue up 21% to £43.1m, recurring revenue up 29%, outlook and cash generation strong.IDOX
H1 20241 Feb 2026 - Revenue up 20%, strong cash flow, and geospatial focus drive growth and margin expansion.IDOX
H2 20249 Jan 2026 - Revenue, EBITDA, and order intake rose, with recurring revenue now 66% of total.IDOX
H1 202513 Nov 2025 - Idox achieved 20% revenue growth and strengthened its geospatial offering with Emapsite.IDOX
Trading Update13 Jun 2025 - Idox anticipates FY25 growth, driven by new contracts and strong financial resources.IDOX
Trading Update6 Jun 2025